Clinical Trials Logo

Stroke, Acute clinical trials

View clinical trials related to Stroke, Acute.

Filter by:

NCT ID: NCT03645590 Completed - Stroke Clinical Trials

Stroke Ready - Optimizing Acute Stroke Care

Start date: June 20, 2018
Phase: N/A
Study type: Interventional

The study aims to increase acute stroke treatment rates in Flint, Michigan through a two-pronged approach of hospital and community level interventions. It also aims to inform future stroke preparedness interventions by exploring the relative importance of hospital optimization and community interventions.

NCT ID: NCT03641963 Suspended - Stroke, Acute Clinical Trials

aICP Measurement in Patients With Cerebral Artery Infarction / aICP MCA Infarction

aICPStroke
Start date: December 1, 2018
Phase: N/A
Study type: Interventional

Space-occupying, malignant middle cerebral artery (M-MCA) infarctions are still one of the most devastating forms of ischemic stroke, with a mortality of up to 80% in untreated patients. It is reported that early hemicraniectomy leads to a substantial decrease in mortality at 6 and 12 months and is likely to improve functional outcome. Thus, this study investigates if non-invasive intracranial pressure (ICP) measuring could represent an objective value to determine the time point to indicate decompressive craniectomy surgery. However, there are still important questions about the individual indication for decompressive surgery. In consideration of a variable clinical course (some patients develop fatal brain edema early, whereas other patients do not show severe brain swelling for several days), achieving a way to measure, control and predict malignant brain edema formation would be of extremely important value.

NCT ID: NCT03634748 Completed - Stroke, Acute Clinical Trials

Thrombolysis in stRoke With Unknown onSet Based on noncontrasT CT

TRUST CT
Start date: September 1, 2017
Phase:
Study type: Observational

Multicentric, observational, registry-based study of 0.9 mg/kg i.v. thrombolysis in wake-up stroke or stroke with unknown onset based on non-contrast CT appearance only

NCT ID: NCT03633422 Completed - Stroke, Acute Clinical Trials

Evaluation of Stroke Patient Screening

Start date: September 25, 2017
Phase:
Study type: Observational [Patient Registry]

Background and Rationale: Traditionally, stroke rehabilitation studies have been performed in stroke patients beyond the first one to three months poststroke [Stinear et al. 2013; Veerbeek et al. 2014]. Acknowledging that early stroke rehabilitation should be initiated soon after stroke onset to optimize stroke outcomes, it is has been stressed that stroke rehabilitation trials should be initiated within the first month [Stinear 2013]. Early stroke rehabilitation trials face difficulties regarding patient recruitment with corresponding low enrollment rates [AVERT 2015; Winters 2015]. Explanations are for example priority given to (sub)acute medical interventions, highly dynamic situation at a stroke unit, and a more rapid change in patients' abilities when compared to patients in later stages poststroke. With the low enrollment rates (~7%), the generalizability of study results is questionable. Participant screening methods and procedures for research eligibility are part of the patient selection and recruitment process in clinical trials. However, no information is available regarding screening procedures and methods for these early initiated stroke rehabilitation trials, including reasons for not enrolling patients. This knowledge is essential to improve screening procedures and methods, in order to optimize patient enrollment and with that, increase the generalizability of study results. Objective: The objective of this project is to evaluate screening methods and procedures for stroke rehabilitation research. Study Design: Observational study

NCT ID: NCT03620370 Completed - Stroke, Acute Clinical Trials

Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke

Start date: August 12, 2018
Phase: N/A
Study type: Interventional

NBO is a nonpharmacological measure of neuroprotection. The purpose of our study is to evaluate the safety and efficiency of NBO(Normobaric hyperoxia) in the acute ischemic stroke patients who received endovascular treatment. Looking for more clinical evidence for the ischemic stroke patients who will be treated with NBO in the future.

NCT ID: NCT03618290 Completed - Stroke, Acute Clinical Trials

Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke

Start date: September 19, 2018
Phase:
Study type: Observational

The purpose of the research is to use plasma free fatty acid profiling as a biomarker for ischemic stroke. The plasma free acid profile will be specifically and significantly changed in early stages upon stroke onset, and correlate with the stroke volume and progression determined by imaging techniques.

NCT ID: NCT03602326 Completed - Ischemic Stroke Clinical Trials

Neurodevelopmental Therapy-Bobath Approach in The Early Term of Stroke; Safe and Effective

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Early term rehabilitation initiated after stroke should be based on motor learning principles and neural plasticity. To achieve motor learning and neural plasticity, exercises consisting of intense and repetitive training should be given according to the patients' functional level. The neurodevelopmental treatment-Bobath (NDT_B) approach is based on motor learning principles. In literature, studies that show the early term effects of NDT-B on functional recovery are inadequate. The aim of this study was to investigate the effects NDT-B applied in the early term of stroke, on postural control, functional movement, balance and activities of daily living.

NCT ID: NCT03592563 Recruiting - Stroke Clinical Trials

CUHK Brain Health Longitudinal Study

BHS
Start date: July 1, 2019
Phase:
Study type: Observational

The goal of this study is to develop a large longitudinal cohort of individuals diagnosed with or at high risk for brain diseases (both neurological and psychiatric in nature), in order to identify risk factors that contribute to neurological and psychiatric diseases over time. The investigators seek to capture relevant information from medical records, electronically administered questionnaires and follow up phone-based interviews. The investigators expect to eventually have sufficient power from our dataset to examine risk factors for a variety of brain disorders, both individually and in aggregate. Our ultimate goal is to offer scientifically validated ways to preserve and promote brain health by working with our patients' needs and tracking their progress over time.

NCT ID: NCT03574467 Completed - Stroke, Acute Clinical Trials

Functional Outcomes of The Bobath Approach on Patients With Brain Tumors: Comparison With Stroke Patients

Start date: February 15, 2018
Phase:
Study type: Observational

The aim of this study is to examine the functional recovery results of the Bobath (NDT) approach in patients with primary brain tumors and compare the results with those of stroke patients.

NCT ID: NCT03574038 Completed - Stroke, Acute Clinical Trials

Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke

TESSERACT
Start date: September 28, 2018
Phase: N/A
Study type: Interventional

This proposal is a prospective, single-center, dose-escalation safety, tolerability, feasibility and potential efficacy study of transcranial direct current stimulation (tDCS) in acute stroke patients with substantial salvageable penumbra due to a large vessel occlusion who are ineligible for intravenous thrombolysis and endovascular therapy.